Open Access Osimertinib Journals
A list of Open Access Osimertinib journals for you to publish your manuscript in
Osimertinib is chemical compound, a third-generation epidermal growth factor receptor tyrosine kinase inhibitor, used as a medication to treat non-small-cell lung carcinomas with a specific mutation
Open Access journals publish research articles that are free to to view and download. The main difference between articles in open access journals and those in closed journals is the business model. Both types of articles have to undergo the same peer review process.
This list of Osimertinib Open Access journals will hopefully make it easier for you to decide where to publish your Osimertinib manuscript.
Our list includes all the high-impact factor Osimertinib journals as well as new journals. This should give you a better idea on where you should publish. In many cases, you only see lists of Osimertinib journals, nonetheless, in our case we have made the list with open access Osimertinib journals in mind.Use our different columns — number of papers, number of citations, and relevance — to find the best Osimertinib venue for your manuscript.
The DOAJ columns refers to the The Directory of Open Access Journals, a list of open access journals, maintained by Infrastructure Services for Open Access.
There are certain criteria a journal must meet to be indexed by DOAJ, and thus inclusion in the DOAJ index is seen by scholars as a mark of quality.
All the open access Osimertinib journals in this list are indexed in OA.mg.
If you spot any mistakes in this table of Osimertinib OA journals, don’t hesitate to send us an email.
Name | ISSN | DOAJ | Publisher | No. of Papers | Citations | Relevance▼ | Website |
---|